(VIANEWS) – Lifeway Foods (LWAY), Kimco Realty Corporation (KIM), iRadimed Corporation (IRMD) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Lifeway Foods (LWAY)
22.9% sales growth and 22.62% return on equity
Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; drinkable yogurt; and fresh made butter and sour cream. It sells its products under the Lifeway, Glen Oaks Farms, and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. The company was incorporated in 1986 and is based in Morton Grove, Illinois.
Earnings Per Share
As for profitability, Lifeway Foods has a trailing twelve months EPS of $0.9.
PE Ratio
Lifeway Foods has a trailing twelve months price to earnings ratio of 21.31. Meaning, the purchaser of the share is investing $21.31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.62%.
Volume
Today’s last reported volume for Lifeway Foods is 109577 which is 37.81% below its average volume of 176204.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.3%, now sitting on 176.78M for the twelve trailing months.
Yearly Top and Bottom Value
Lifeway Foods’s stock is valued at $19.18 at 06:22 EST, way under its 52-week high of $28.61 and way above its 52-week low of $9.06.
Moving Average
Lifeway Foods’s value is way above its 50-day moving average of $13.93 and way above its 200-day moving average of $14.93.
2. Kimco Realty Corporation (KIM)
12.3% sales growth and 3.64% return on equity
Kimco Realty Corp. (NYSE:KIM) is a real estate investment trust (REIT) headquartered in Jericho, N.Y. that is one of North America's largest publicly traded owners and operators of open-air, grocery-anchored shopping centers and mixed-use assets. As of June 30, 2020, the company owned interests in 400 U.S. shopping centers and mixed-use assets comprising 70 million square feet of gross leasable space primarily concentrated in the top major metropolitan markets. Publicly traded on the NYSE since 1991, and included in the S&P 500 Index, the company has specialized in shopping center acquisitions, development and management for more than 60 years.
Earnings Per Share
As for profitability, Kimco Realty Corporation has a trailing twelve months EPS of $0.54.
PE Ratio
Kimco Realty Corporation has a trailing twelve months price to earnings ratio of 43.31. Meaning, the purchaser of the share is investing $43.31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.64%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13%, now sitting on 1.9B for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Sep 5, 2024, the estimated forward annual dividend rate is 0.96 and the estimated forward annual dividend yield is 4.13%.
3. iRadimed Corporation (IRMD)
10.4% sales growth and 25.08% return on equity
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Earnings Per Share
As for profitability, iRadimed Corporation has a trailing twelve months EPS of $1.46.
PE Ratio
iRadimed Corporation has a trailing twelve months price to earnings ratio of 32.16. Meaning, the purchaser of the share is investing $32.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.08%.
Yearly Top and Bottom Value
iRadimed Corporation’s stock is valued at $46.96 at 06:22 EST, below its 52-week high of $50.93 and way higher than its 52-week low of $36.12.
Volume
Today’s last reported volume for iRadimed Corporation is 33513 which is 36.37% below its average volume of 52671.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.2%, now sitting on 69.48M for the twelve trailing months.
Sales Growth
iRadimed Corporation’s sales growth is 9.7% for the current quarter and 10.4% for the next.
4. CONMED Corporation (CNMD)
5.6% sales growth and 11.86% return on equity
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Earnings Per Share
As for profitability, CONMED Corporation has a trailing twelve months EPS of $3.14.
PE Ratio
CONMED Corporation has a trailing twelve months price to earnings ratio of 23.32. Meaning, the purchaser of the share is investing $23.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.86%.
Volume
Today’s last reported volume for CONMED Corporation is 410616 which is 3.21% below its average volume of 424255.
